AMPLIA THERAPEUTICS ORDINARY (ATX) Short Interest
AMPLIA THERAPEUTICS ORDINARY (ASX:ATX) had 0.01% of shares reported as short positions as of 5 June 2026, representing 43,819 shares. AMPLIA THERAPEUTICS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 0.01%
- Reported positions
- 43,819
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 5 June 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
ATX
Amplia Therapeutics
Amplia Therapeutics Limited focuses on developing therapies targeting focal adhesion kinase (FAK) inhibitors for the treatment of cancer and fibrosis. The company is positioned within the biotechnology sector, leveraging advanced scientific research to develop clinical candidates aimed at unmet medical needs, potentially offering transformative therapies in oncology and fibrotic diseases.